Home›People›Amir Nashat, Sc.D.
AD

Amir Nashat, Sc.D.

Director at Dewpoint Therapeutics.

Director
Updated Nov 2, 2026·Latest SEC filing Jul 13, 2026·Suggest an edit

About Amir Nashat, Sc.D.

Amir Nashat, Sc.D. is a director at Dewpoint Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Amir Nashat, Sc.D. in the role, so the role may have started earlier or lasted longer.

Dewpoint Therapeutics, Inc.
Director
2026 · Boston, MA
Develops drug candidates for people with cancer and neurological diseases.

Key Colleagues at Startups

The people Amir Nashat, Sc.D. works with at each company, as listed on that company's latest Form D.

Dewpoint Therapeutics, Inc. · Form D/A, Jul 13, 2026
ID
Isaac Klein, M.D., Ph.D.
Chief Scientific Officer and Head of R&D
AD
Ameet Nathwani, M.D.
Chief Executive Officer and director

Sources

  1. SECDewpoint Therapeutics, Inc. Form D/A, filed Jul 13, 2026